BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Haqq AM, Muehlbauer MJ, Newgard CB, Grambow S, Freemark M. The metabolic phenotype of Prader-Willi syndrome (PWS) in childhood: heightened insulin sensitivity relative to body mass index. J Clin Endocrinol Metab 2011;96:E225-32. [PMID: 20962018 DOI: 10.1210/jc.2010-1733] [Cited by in Crossref: 51] [Cited by in F6Publishing: 47] [Article Influence: 4.3] [Reference Citation Analysis]
Number Citing Articles
1 Griggs JL, Sinnayah P, Mathai ML. Prader–Willi syndrome: From genetics to behaviour, with special focus on appetite treatments. Neuroscience & Biobehavioral Reviews 2015;59:155-72. [DOI: 10.1016/j.neubiorev.2015.10.003] [Cited by in Crossref: 22] [Cited by in F6Publishing: 23] [Article Influence: 3.1] [Reference Citation Analysis]
2 Miller JL, Linville TD, Dykens EM. Effects of metformin in children and adolescents with Prader-Willi syndrome and early-onset morbid obesity: a pilot study. J Pediatr Endocrinol Metab 2014;27:23-9. [PMID: 23893676 DOI: 10.1515/jpem-2013-0116] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 1.8] [Reference Citation Analysis]
3 Emerick JE, Vogt KS. Endocrine manifestations and management of Prader-Willi syndrome. Int J Pediatr Endocrinol 2013;2013:14. [PMID: 23962041 DOI: 10.1186/1687-9856-2013-14] [Cited by in Crossref: 51] [Cited by in F6Publishing: 50] [Article Influence: 5.7] [Reference Citation Analysis]
4 Bervini S, Herzog H. Mouse models of Prader-Willi Syndrome: a systematic review. Front Neuroendocrinol 2013;34:107-19. [PMID: 23391702 DOI: 10.1016/j.yfrne.2013.01.002] [Cited by in Crossref: 53] [Cited by in F6Publishing: 48] [Article Influence: 5.9] [Reference Citation Analysis]
5 Grugni G, Crinò A, Bedogni G, Cappa M, Sartorio A, Corrias A, Di Candia S, Gargantini L, Iughetti L, Pagano C, Ragusa L, Salvatoni A, Spera S, Vettor R, Chiumello G, Brambilla P. Metabolic syndrome in adult patients with Prader-Willi syndrome. Nutr Metab Cardiovasc Dis 2013;23:1134-40. [PMID: 23220075 DOI: 10.1016/j.numecd.2012.11.006] [Cited by in Crossref: 29] [Cited by in F6Publishing: 27] [Article Influence: 2.9] [Reference Citation Analysis]
6 Goldstone AP, Holland AJ, Butler JV, Whittington JE. Appetite hormones and the transition to hyperphagia in children with Prader-Willi syndrome. Int J Obes (Lond) 2012;36:1564-70. [PMID: 22270375 DOI: 10.1038/ijo.2011.274] [Cited by in Crossref: 37] [Cited by in F6Publishing: 30] [Article Influence: 3.7] [Reference Citation Analysis]
7 Hirsch HJ, Gross I, Pollak Y, Eldar-Geva T, Gross-Tsur V. Irisin and the Metabolic Phenotype of Adults with Prader-Willi Syndrome. PLoS One 2015;10:e0136864. [PMID: 26334732 DOI: 10.1371/journal.pone.0136864] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 2.0] [Reference Citation Analysis]
8 Rubin DA, Clark SJ, Haqq AM, Castner DM, Ng J, Judelson DA. Hormonal and Metabolic Responses to a Single Bout of Resistance Exercise in Prader-Willi Syndrome
. Horm Res Paediatr 2017;87:153-61. [PMID: 28253507 DOI: 10.1159/000454805] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
9 Crinò A, Grugni G. Update on Diabetes Mellitus and Glucose Metabolism Alterations in Prader-Willi Syndrome. Curr Diab Rep 2020;20:7. [PMID: 32030506 DOI: 10.1007/s11892-020-1284-5] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 6.0] [Reference Citation Analysis]
10 Olsson LM, Poitou C, Tremaroli V, Coupaye M, Aron-Wisnewsky J, Bäckhed F, Clément K, Caesar R. Gut microbiota of obese subjects with Prader-Willi syndrome is linked to metabolic health. Gut 2020;69:1229-38. [PMID: 31611297 DOI: 10.1136/gutjnl-2019-319322] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 5.3] [Reference Citation Analysis]
11 Orsso CE, Butler AA, Muehlbauer MJ, Cui HN, Rubin DA, Pakseresht M, Butler MG, Prado CM, Freemark M, Haqq AM. Obestatin and adropin in Prader-Willi syndrome and nonsyndromic obesity: Associations with weight, BMI-z, and HOMA-IR. Pediatr Obes 2019;14:e12493. [PMID: 30589518 DOI: 10.1111/ijpo.12493] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
12 Lloret-Linares C, Faucher P, Coupaye M, Alili R, Green A, Basdevant A, Clément K, Poitou C. Comparison of body composition, basal metabolic rate and metabolic outcomes of adults with Prader Willi syndrome or lesional hypothalamic disease, with primary obesity. Int J Obes (Lond) 2013;37:1198-203. [PMID: 23318724 DOI: 10.1038/ijo.2012.228] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 2.0] [Reference Citation Analysis]
13 Chen H, Victor AK, Klein J, Tacer KF, Tai DJ, de Esch C, Nuttle A, Temirov J, Burnett LC, Rosenbaum M, Zhang Y, Ding L, Moresco JJ, Diedrich JK, Yates JR 3rd, Tillman HS, Leibel RL, Talkowski ME, Billadeau DD, Reiter LT, Potts PR. Loss of MAGEL2 in Prader-Willi syndrome leads to decreased secretory granule and neuropeptide production. JCI Insight 2020;5:138576. [PMID: 32879135 DOI: 10.1172/jci.insight.138576] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
14 Yang A, Kim J, Cho SY, Jin DK. Prevalence and risk factors for type 2 diabetes mellitus with Prader-Willi syndrome: a single center experience. Orphanet J Rare Dis 2017;12:146. [PMID: 28854950 DOI: 10.1186/s13023-017-0702-5] [Cited by in Crossref: 10] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
15 Alsaif M, Pakseresht M, Mackenzie ML, Gaylinn B, Thorner MO, Freemark M, Field CJ, Prado CM, Haqq AM. Dietary macronutrient regulation of acyl and desacyl ghrelin concentrations in children with Prader-Willi syndrome (PWS). Clin Endocrinol (Oxf) 2020;93:579-89. [PMID: 32638409 DOI: 10.1111/cen.14279] [Reference Citation Analysis]
16 Crinò A, Fintini D, Bocchini S, Grugni G. Obesity management in Prader-Willi syndrome: current perspectives. Diabetes Metab Syndr Obes 2018;11:579-93. [PMID: 30323638 DOI: 10.2147/DMSO.S141352] [Cited by in Crossref: 42] [Cited by in F6Publishing: 27] [Article Influence: 10.5] [Reference Citation Analysis]
17 Heksch R, Kamboj M, Anglin K, Obrynba K. Review of Prader-Willi syndrome: the endocrine approach. Transl Pediatr 2017;6:274-85. [PMID: 29184809 DOI: 10.21037/tp.2017.09.04] [Cited by in Crossref: 38] [Cited by in F6Publishing: 31] [Article Influence: 7.6] [Reference Citation Analysis]
18 Bueno M, Boixadera-Planas E, Blanco-Hinojo L, Esteba-Castillo S, Giménez-Palop O, Torrents-Rodas D, Pujol J, Corripio R, Deus J, Caixàs A. Hunger and Satiety Peptides: Is There a Pattern to Classify Patients with Prader-Willi Syndrome? J Clin Med 2021;10:5170. [PMID: 34768690 DOI: 10.3390/jcm10215170] [Reference Citation Analysis]
19 Hirsch HJ, Gross-Tsur V, Sabag Y, Nice S, Genstil L, Benarroch F, Constantini N. Myokine levels after resistance exercise in young adults with Prader-Willi syndrome (PWS). Am J Med Genet A 2020;182:115-21. [PMID: 31692257 DOI: 10.1002/ajmg.a.61391] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
20 Fintini D, Grugni G, Bocchini S, Brufani C, Di Candia S, Corrias A, Delvecchio M, Salvatoni A, Ragusa L, Greggio N, Franzese A, Scarano E, Trifirò G, Mazzanti L, Chiumello G, Cappa M, Crinò A. Disorders of glucose metabolism in Prader–Willi syndrome: Results of a multicenter Italian cohort study. Nutrition, Metabolism and Cardiovascular Diseases 2016;26:842-7. [DOI: 10.1016/j.numecd.2016.05.010] [Cited by in Crossref: 31] [Cited by in F6Publishing: 24] [Article Influence: 5.2] [Reference Citation Analysis]
21 Orsso CE, Mackenzie M, Alberga AS, Sharma AM, Richer L, Rubin DA, Prado CM, Haqq AM. The use of magnetic resonance imaging to characterize abnormal body composition phenotypes in youth with Prader-Willi syndrome. Metabolism 2017;69:67-75. [PMID: 28285653 DOI: 10.1016/j.metabol.2017.01.020] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 2.2] [Reference Citation Analysis]
22 Fujiwara K, Hasegawa K, Ohkumo T, Miyoshi H, Tseng YH, Yoshikawa K. Necdin controls proliferation of white adipocyte progenitor cells. PLoS One 2012;7:e30948. [PMID: 22292082 DOI: 10.1371/journal.pone.0030948] [Cited by in Crossref: 35] [Cited by in F6Publishing: 35] [Article Influence: 3.5] [Reference Citation Analysis]
23 Goltz D, Schötta K, Zhou H, Fischer H. Nichtalkoholische Steatohepatitis mit Zirrhose bei jungen Erwachsenen mit hypothalamisch-hypophysärer Dysfunktion. Pathologe 2013;34:318-22. [DOI: 10.1007/s00292-012-1735-0] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
24 Irizarry KA, Bain J, Butler MG, Ilkayeva O, Muehlbauer M, Haqq AM, Freemark M. Metabolic profiling in Prader-Willi syndrome and nonsyndromic obesity: sex differences and the role of growth hormone. Clin Endocrinol (Oxf) 2015;83:797-805. [PMID: 25736874 DOI: 10.1111/cen.12766] [Cited by in Crossref: 19] [Cited by in F6Publishing: 18] [Article Influence: 2.7] [Reference Citation Analysis]
25 Deal CL, Tony M, Höybye C, Allen DB, Tauber M, Christiansen JS; 2011 Growth Hormone in Prader-Willi Syndrome Clinical Care Guidelines Workshop Participants. GrowthHormone Research Society workshop summary: consensus guidelines for recombinant human growth hormone therapy in Prader-Willi syndrome. J Clin Endocrinol Metab 2013;98:E1072-87. [PMID: 23543664 DOI: 10.1210/jc.2012-3888] [Cited by in Crossref: 174] [Cited by in F6Publishing: 144] [Article Influence: 19.3] [Reference Citation Analysis]
26 McAlister KL, Fisher KL, Dumont-Driscoll MC, Rubin DA. The relationship between metabolic syndrome, cytokines and physical activity in obese youth with and without Prader-Willi syndrome. J Pediatr Endocrinol Metab 2018;31:837-45. [PMID: 29975666 DOI: 10.1515/jpem-2017-0539] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 1.5] [Reference Citation Analysis]
27 Angulo MA, Butler MG, Cataletto ME. Prader-Willi syndrome: a review of clinical, genetic, and endocrine findings. J Endocrinol Invest 2015;38:1249-63. [PMID: 26062517 DOI: 10.1007/s40618-015-0312-9] [Cited by in Crossref: 254] [Cited by in F6Publishing: 203] [Article Influence: 36.3] [Reference Citation Analysis]
28 Bedogni G, Grugni G, Nobili V, Agosti F, Saezza A, Sartorio A. Is non-alcoholic fatty liver disease less frequent among women with Prader-Willi syndrome? Obes Facts 2014;7:71-6. [PMID: 24577228 DOI: 10.1159/000358570] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 2.0] [Reference Citation Analysis]
29 Fintini D, Inzaghi E, Colajacomo M, Bocchini S, Grugni G, Brufani C, Cappa M, Nobili V, Cianfarani S, Crinò A. Non-Alcoholic Fatty Liver Disease (NAFLD) in children and adolescents with Prader-Willi Syndrome (PWS): NAFLD in PWS children. Pediatric Obesity 2016;11:235-8. [DOI: 10.1111/ijpo.12052] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.1] [Reference Citation Analysis]
30 Clerc A, Coupaye M, Mosbah H, Pinto G, Laurier V, Mourre F, Merrien C, Diene G, Poitou C, Tauber M. Diabetes Mellitus in Prader-Willi Syndrome: Natural History during the Transition from Childhood to Adulthood in a Cohort of 39 Patients. J Clin Med 2021;10:5310. [PMID: 34830599 DOI: 10.3390/jcm10225310] [Reference Citation Analysis]
31 Rubin DA, Duran AT, Haqq AM, Gertz ER, Dumont-Driscoll M. Changes in cardiometabolic markers in children with Prader-Willi syndrome and nonsyndromic obesity following participation in a home-based physical activity intervention. Pediatr Obes 2018;13:734-43. [PMID: 30280511 DOI: 10.1111/ijpo.12462] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 1.5] [Reference Citation Analysis]
32 Cadoudal T, Buléon M, Sengenès C, Diene G, Desneulin F, Molinas C, Eddiry S, Conte-Auriol F, Daviaud D, Martin PG, Bouloumié A, Salles JP, Tauber M, Valet P. Impairment of adipose tissue in Prader-Willi syndrome rescued by growth hormone treatment. Int J Obes (Lond) 2014;38:1234-40. [PMID: 24406482 DOI: 10.1038/ijo.2014.3] [Cited by in Crossref: 13] [Cited by in F6Publishing: 10] [Article Influence: 1.6] [Reference Citation Analysis]
33 Cardona Cano S, Merkestein M, Skibicka KP, Dickson SL, Adan RA. Role of Ghrelin in the Pathophysiology of Eating Disorders: Implications for Pharmacotherapy. CNS Drugs 2012;26:281-96. [DOI: 10.2165/11599890-000000000-00000] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 1.3] [Reference Citation Analysis]
34 Lucas-herald AK, Perry CG, Shaikh MG. Review of growth hormone therapy in adolescents and young adults with Prader–Willi syndrome. Expert Review of Endocrinology & Metabolism 2014;10:259-67. [DOI: 10.1586/17446651.2015.1007126] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
35 Irizarry KA, Miller M, Freemark M, Haqq AM. Prader Willi Syndrome: Genetics, Metabolomics, Hormonal Function, and New Approaches to Therapy. Adv Pediatr 2016;63:47-77. [PMID: 27426895 DOI: 10.1016/j.yapd.2016.04.005] [Cited by in Crossref: 41] [Cited by in F6Publishing: 34] [Article Influence: 10.3] [Reference Citation Analysis]
36 Muscogiuri G, Barrea L, Faggiano F, Maiorino MI, Parrillo M, Pugliese G, Ruggeri RM, Scarano E, Savastano S, Colao A; RESTARE. Obesity in Prader-Willi syndrome: physiopathological mechanisms, nutritional and pharmacological approaches. J Endocrinol Invest 2021;44:2057-70. [PMID: 33891302 DOI: 10.1007/s40618-021-01574-9] [Reference Citation Analysis]
37 Tauber M, Hoybye C. Endocrine disorders in Prader-Willi syndrome: a model to understand and treat hypothalamic dysfunction. Lancet Diabetes Endocrinol 2021;9:235-46. [PMID: 33647242 DOI: 10.1016/S2213-8587(21)00002-4] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 7.0] [Reference Citation Analysis]
38 Burnett LC, Hubner G, LeDuc CA, Morabito MV, Carli JFM, Leibel RL. Loss of the imprinted, non-coding Snord116 gene cluster in the interval deleted in the Prader Willi syndrome results in murine neuronal and endocrine pancreatic developmental phenotypes. Hum Mol Genet 2017;26:4606-16. [PMID: 28973544 DOI: 10.1093/hmg/ddx342] [Cited by in Crossref: 19] [Cited by in F6Publishing: 15] [Article Influence: 4.8] [Reference Citation Analysis]
39 Irizarry KA, Mager DR, Triador L, Muehlbauer MJ, Haqq AM, Freemark M. Hormonal and metabolic effects of carbohydrate restriction in children with Prader-Willi syndrome. Clin Endocrinol (Oxf) 2019;90:553-61. [PMID: 30614551 DOI: 10.1111/cen.13933] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
40 Shi SQ, Bichell TJ, Ihrie RA, Johnson CH. Ube3a imprinting impairs circadian robustness in Angelman syndrome models. Curr Biol 2015;25:537-45. [PMID: 25660546 DOI: 10.1016/j.cub.2014.12.047] [Cited by in Crossref: 49] [Cited by in F6Publishing: 43] [Article Influence: 7.0] [Reference Citation Analysis]
41 Tanaka Y, Abe Y, Oto Y, Itabashi H, Shiraishi M, Yoshino A, Obata K, Murakami N, Nagai T. Characterization of fat distribution in Prader-Willi syndrome: relationships with adipocytokines and influence of growth hormone treatment. Am J Med Genet A 2013;161A:27-33. [PMID: 23239671 DOI: 10.1002/ajmg.a.35653] [Cited by in Crossref: 16] [Cited by in F6Publishing: 15] [Article Influence: 1.6] [Reference Citation Analysis]
42 Rigamonti AE, Bini S, Grugni G, Agosti F, De Col A, Mallone M, Cella SG, Sartorio A. Unexpectedly increased anorexigenic postprandial responses of PYY and GLP-1 to fast ice cream consumption in adult patients with Prader-Willi syndrome. Clin Endocrinol 2014;81:542-50. [DOI: 10.1111/cen.12395] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
43 Ferretti G, Bacchetti T, Masciangelo S, Grugni G, Bicchiega V. Altered inflammation, paraoxonase-1 activity and HDL physicochemical properties in obese humans with and without Prader-Willi syndrome. Dis Model Mech 2012;5:698-705. [PMID: 22822045 DOI: 10.1242/dmm.009209] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 1.2] [Reference Citation Analysis]
44 McCandless SE, Yanovski JA, Miller J, Fu C, Bird LM, Salehi P, Chan CL, Stafford D, Abuzzahab MJ, Viskochil D, Barlow SE, Angulo M, Myers SE, Whitman BY, Styne D, Roof E, Dykens EM, Scheimann AO, Malloy J, Zhuang D, Taylor K, Hughes TE, Kim DD, Butler MG. Effects of MetAP2 inhibition on hyperphagia and body weight in Prader-Willi syndrome: A randomized, double-blind, placebo-controlled trial. Diabetes Obes Metab 2017;19:1751-61. [PMID: 28556449 DOI: 10.1111/dom.13021] [Cited by in Crossref: 48] [Cited by in F6Publishing: 42] [Article Influence: 9.6] [Reference Citation Analysis]
45 Mele C, Crinò A, Fintini D, Mai S, Convertino A, Bocchini S, Di Paolo P, Grugni G, Aimaretti G, Scacchi M, Marzullo P. Angiopoietin-like 8 (ANGPTL8) as a potential predictor of NAFLD in paediatric patients with Prader-Willi Syndrome. J Endocrinol Invest 2021;44:1447-56. [PMID: 33067796 DOI: 10.1007/s40618-020-01444-w] [Reference Citation Analysis]
46 Guevara-Aguirre J, Rosenbloom AL, Balasubramanian P, Teran E, Guevara-Aguirre M, Guevara C, Procel P, Alfaras I, De Cabo R, Di Biase S, Narvaez L, Saavedra J, Longo VD. GH Receptor Deficiency in Ecuadorian Adults Is Associated With Obesity and Enhanced Insulin Sensitivity. J Clin Endocrinol Metab 2015;100:2589-96. [PMID: 25985182 DOI: 10.1210/jc.2015-1678] [Cited by in Crossref: 43] [Cited by in F6Publishing: 38] [Article Influence: 6.1] [Reference Citation Analysis]
47 Huang WK, Wong SZH, Pather SR, Nguyen PTT, Zhang F, Zhang DY, Zhang Z, Lu L, Fang W, Chen L, Fernandes A, Su Y, Song H, Ming GL. Generation of hypothalamic arcuate organoids from human induced pluripotent stem cells. Cell Stem Cell 2021;28:1657-1670.e10. [PMID: 33961804 DOI: 10.1016/j.stem.2021.04.006] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
48 Correa-da-Silva F, Fliers E, Swaab DF, Yi CX. Hypothalamic neuropeptides and neurocircuitries in Prader Willi syndrome. J Neuroendocrinol 2021;33:e12994. [PMID: 34156126 DOI: 10.1111/jne.12994] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
49 Khan MJ, Gerasimidis K, Edwards CA, Shaikh MG. Mechanisms of obesity in Prader-Willi syndrome. Pediatr Obes 2018;13:3-13. [PMID: 27863129 DOI: 10.1111/ijpo.12177] [Cited by in Crossref: 35] [Cited by in F6Publishing: 28] [Article Influence: 5.8] [Reference Citation Analysis]